NEOGENOMICS INC — Director's Dealing 2019

Mar 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2019-02-27

Reporting Person: CARDOZA GEORGE (President, Pharma Services)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-27	Common Stock	M	30000	$3.45	Acquired	244089	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-27	Stock Option (Right to Buy)	$3.45	M	30000	Disposed	2019-03-05	Common Stock (30000.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	20000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.15	2021-04-20	Common Stock (200000.0)	200000	Direct
Stock Option (Right to Buy)	$4.78	2020-05-04	Common Stock (200000.0)	200000	Direct
Stock Option (Right to Buy)	$7.52	2022-04-28	Common Stock (200000.0)	200000	Direct
Stock Options (Right to Buy)	$8.03	2023-02-26	Common Stock (192500.0)	192500	Direct

Footnotes

F1: The total includes 16,667 shares of unvested restricted stock that were previously reported in Table II.

F2: On March 5, 2014 Mr. Cardoza was granted an option to purchase 30,000 shares. These options vest ratably over the first three anniversary dates of the grant.

F3: On April 20, 2016, Mr. Cardoza was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F4: On May 4, 2015 Mr. Cardoza was granted an option to purchase 200,000 shares. These options vest ratably over the first three anniversary dates of the grant.

F5: On April 28, 2017, Mr. Cardoza was granted 200,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.

F6: On February 26, 2018, Mr. Cardoza was granted 192,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.